Why Healthcare needs Regulatory Intelligence done differently.
Pharmaceutical technology lives under FDA 21 CFR Part 11. Data integrity isn't optional — it's existential. Clinical trial data, manufacturing execution, regulatory submissions — every system requires validated, compliant infrastructure. The Regulatory Intelligence challenge in Healthcare — Pharmaceuticals & Life Sciences is compounded by regulatory requirements that most engineering teams treat as an afterthought. Our teams deploy with real-time regulatory monitoring built in. Doing this right in healthcare means building compliance into the architecture before writing a single line of business logic.
How We Deliver
Regure monitors regulatory changes across every jurisdiction we serve — US, UK, UAE, Australia, India. When HIPAA guidance updates, when FCA publishes new rules, when UAE PDPL adds requirements — the system identifies the delta, translates it into technical requirements, and queues the engineering response. Your legal team hears about the change from a press release. Your engineering team already has a ticket. In healthcare, this means FDA 21 CFR PART 11 and HIPAA compliance is enforced at every commit.
Related Platforms
These aren't products we sell. They're capabilities embedded in every engagement of this type.